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Abstract
The structures of two diastereoisomers of norbormide (C33H25N3O3, one as an ethyl acetate hemi-solvate
C33H25N3O3·0.5(C4H8O2) have been unambiguously determined. They differ in the relative stereochemistry of the exo-
cyclic double bond and the relative conformations of the aryl rings. Each is involved in both intra- and inter-molecular
hydrogen bonding.
Comment
AUTHOR: Please check that the Bova references (2001a, 2001b) are correctly identified. *Yes they are*
Norbormide is a compound discovered in the early 1960 s that is selectively toxic to rats and relatively harmless to other
rodents and mammals (Roszkowski, 1965). It exerts its lethality in the rat through mechanisms involving the control of
blood pressure. Evidence suggests that norbormide acts by stimulating a number of signal transduction pathways that lead
to modulation of calcium influx, presumably mediated by cell membrane receptor(s) (Bova et al., 2001a). Physiological
studies indicate that norbormide elicits divergent tissue responses, causing selective vasoconstriction of small arteries and
vasodilation of large blood vessels in the rat, whilst dilating both small and large blood vessels of other species (Bova et
al., 2001b).
We recently synthesized and purified six of the eight racemic diastereoisomers of norbormide and undertook a struc-
ture-activity relationship study of these isomers with respect to vasorelaxant and vasoconstrictor properties (Brimble et
al., 2003). These isomers differ according to the stereochemistry (cis/trans) of the exocyclic double bond, the orientation
(endo/exo) of the maleimide ring and the stereochemistry (erythro/threo) of the tertiary alcohol. The contrasting responses
of the different isomers to this toxin may be the key to understanding the secret of species-specificity of drug action and
provides opportunities for developing more species-selective pesticides.
Our initial work in this area (Brimble et al., 2003) established that the cis-endo-threo isomer (1a) of norbormide exhibited
the most potent vasoconstrictor properties and is a lead compound for analogue development. We herein report the crystal
structures of the cis-endo-threo isomer (1a) and the trans-endo-threo isomer (1 b) of norbormide in order to unambiguously
confirm their structures and to facilitate molecular modelling studies for the construction of analogues. At the outset of this
work only a crystal structure of the N-bromobenzyl derivative of (1a) was available (Abrahamsson & Nilsson, 1966) and
we were keen to obtain the three-dimensional coordinates for the parent compounds.
Acta C preprint
2
[Structures of (1a) and (1 b) here]
Figure 1 shows a perspective view of the structure of isomer (1a), which crystallizes in the monoclinic space group
P21/n. This unambiguously confirms that the most potent isomer is indeed that in which the exocyclic double bond has the
2-pyridyl substituent cis to the diarylmethanol substituent, which has threo stereochemistry, and the maleimide ring has an
endo configuration. Within the molecule the hydroxyl group is involved in an intramolecular hydrogen bond to the adjacent
pyridine ring (Table 1). Intermolecular interactions form centrosymmetric pairs of linear H-bonds [graph set notation R22(8)]
between the NH and O3 of the maleimide groups (Table 1). AUTHOR: Please check additon to last sentence. *Correct*
[Figure 1 and Table 1 here]
Figure 2 shows the structure of isomer (1 b), which crystallizes in the monoclinic space group P2/c along with half a
solvate molecule of ethyl acetate, which is disordered about a 2-fold rotation axis. This isomer differs from (1a) in having
the opposite stereochemistry of the exocyclic double bond. That is, the pyridine ring, involving N31, has a trans relationship
relative to the diarylmethanol substituent. Another difference between the two structures is that the four aryl (phenyl and
2-pyridyl) substituents have very different torsional orientations. Once again the OH group is involved in an intramolecular
H-bond to N11. However, in this case the hydrogen bonding is bifurcated with an additional, albeit weaker, interaction with
O3 of the maleimide ring (Table 2). Adjacent molecules are again connected by linear intermolecular H-bonds involving
the maleimide groups, [graph set notation R22(8)] although in this case the molecules are related by a twofold axis (Table
2). AUTHOR: Please check the assertion about the glide plane in the last sentence. I think the molecules are related by
a twofold axis (−x, y, 0.5 − z). *You are absolutely correct. My apologies for this inexcusable error!* Also approve the
addition. *Okay*
[Figure 2 and Table 2 here]
During the course of this work we also indirectly confirmed the structure of a third isomer. Several datasets were collec-
ted using crystals of isomer (1a) contaminated with varying amounts of another isomer. In each case the isomer ratio was
independently determined by 1H NMR and was found to vary between 2:1 and 4:1. These crystals were all isomorphous
with those of pure (1a) (see above) and refined with disorder of the two aryl rings attached to the tertiary alcohol centre.
Specifically the rings attached to that centre had different conformations, presumably as a consequence of a different hy-
drogen bonding pattern. This therefore identified the minor component as the cis-endo-erythro isomer.
Experimental
The title compounds were prepared, and recrystallized from ethyl acetate, as described previously (Brimble et al., 2003).
Refinement
AUTHOR: Please confirm the following re-wording is correct *Yes*
Crystal decay was monitored by the measurement of duplicate reflections and was found to be negligible. OH and NH
H atoms were located from difference Fourier syntheses and their positions refined, with an N—H bond length restraint
of 0.95 (2) Å in isomer 1 b, and with Uiso(H) = 1.5Ueq(N). CH H atoms were placed in calculated positions, with C—H
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distances set at 0.95 Å (aryl and alkene H) or 1.00 Å (methine H), and refined as riding, with Uiso(H) = 1.2Ueq(C), except
for the solvate methyl H atoms which have Uiso(H) = 1.5Ueq(C).
AUTHOR: fine-focus or normal-focus sealed tube? *Fine-focus, as stated below*
Computing details
For both compounds, data collection: Bruker SMART (Bruker, 1997); cell refinement: Bruker SAINT (Bruker, 1997); data
reduction: Bruker SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 1990); program(s) used to refine struc-
ture: SHELXL97 (Sheldrick, 1997); molecular graphics: Bruker SHELXTL ((Bruker, 1997)); software used to prepare ma-
terial for publication: Bruker SHELXTL
Figures
Figure 1. Perspective view and atom-numbering scheme of 1a. The wholly obscured atom C45 is not labelled. Displace-
ment ellipsoids are drawn at the 30% probability level.
Figure 2. Perspective view and atom-numbering scheme of 1 b. Displacement ellipsoids are drawn at the 30% probability
level. The disordered ethyl acetate solvate molecule is not shown.
(1a)
Crystal data
C33H25N3O3 V = 2717.6 (13) Å3
Mr = 511.56 Z = 4
Monoclinic, P21/n Mo Kα
a = 15.433 (4) Å µ = 0.08 mm−1
b = 11.437 (3) Å T = 163 (2) K
c = 17.048 (5) Å 0.59 × 0.48 × 0.04 mm
β = 115.427 (3)º
Data collection
Bruker SMART CCD area detector
diffractometer 4795 independent reflections
Absorption correction: multi-scan
(SADABS; Sheldrick, 2002) 3147 reflections with I > 2σ(I)
Tmin = 0.744, Tmax = 1.000 Rint = 0.049
28763 measured reflections
Refinement
R[F2 > 2σ(F2)] = 0.041 358 parameters
wR(F2) = 0.102
H atoms treated by a mixture of
independent and constrained refinement
S = 1.08 Δρmax = 0.15 e Å−3
4795 reflections Δρmin = −0.19 e Å−3
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Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
O1—H1B···N11 0.79 (2) 2.12 (3) 2.645 (2) 125 (2)
N1—H1C···O3i 0.95 (2) 2.02 (2) 2.965 (2) 174 (2)
Symmetry codes: (i) −x, −y+1, −z+2.
(1b)
Crystal data
C33H25N3O3·0.5(C4H8O2) V = 2771.9 (8) Å3
Mr = 555.61 Z = 4
Monoclinic, P2/c Mo Kα
a = 17.999 (3) Å µ = 0.09 mm−1
b = 12.614 (2) Å T = 173 (2) K
c = 13.063 (2) Å 0.48 × 0.12 × 0.08 mm
β = 110.834 (2)º
Data collection
Bruker SMART CCD area detector
diffractometer 4870 independent reflections
Absorption correction: multi-scan
(SADABS; Sheldrick, 2002) 1989 reflections with I > 2σ(I)
Tmin = 0.738, Tmax = 1.000 Rint = 0.159
31232 measured reflections
Refinement
R[F2 > 2σ(F2)] = 0.062 1 restraint
wR(F2) = 0.125
H atoms treated by a mixture of
independent and constrained refinement
S = 0.89 Δρmax = 0.21 e Å−3
4870 reflections Δρmin = −0.23 e Å−3
396 parameters
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
O1—H1B···N11 0.93 (3) 2.30 (3) 2.765 (4) 111 (3)
O1—H1B···O3 0.93 (3) 2.33 (3) 2.917 (3) 121 (3)
N1—H1C···O2i 0.92 (3) 1.94 (3) 2.863 (4) 175 (3)
Symmetry codes: (i) −x+1, y, −z+1/2.
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